| Code |
| CARE |
| Title |
| PT Metro Healthcare Indonesia Tbk |
| Address |
|
| Background |
The Company is engaged in management consulting services and investing inSubsidiaries. |
| Business cp product |
The Company is engaged in management consulting services and investing inSubsidiaries. |
| Subsidiary affiliation |
| Subsidiaries | Domicile | Business | % | | Direct Owners | | | | | PT Metro Global Medika | Tangerang | Hospital activities, private clinics | 99.99 | | PT Metro Helathcare Technologies | Tangerang | Hospital activities, private clinics | 99.99 | | PT Metro Medika Abadi | Jakarta | Trading | 99.99 |
|
| Commissioners |
| President Commissioner | : dr. Agustinus Widjaja, C.Ht | | | Independent Commissioner | : dr. Rico Novyanto, Sp.PD | | | | | | Per 30 Sep 2023 | | |
|
| Directors |
| President Director | : Ir. Henry Kembaren, MM | | | Director | : dr. Dedi Tedjakusnadi, MARS | | | | | | Per 30 Sep 2023 | | |
|
| Underwriter |
| PT. Pacific Sekuritas Indonesia | | | PT. Jasa Utama Capital Sekuritas | |
| Share registrar |
|
| Share holders |
| Shareholders | Shares | % | | | | PT Metro Healthcare International | 16599999999 | 49.92 | | | | Bank Julius Baer and Co LTD Singapore | 6649000000 | 20 | | | | PT Capital Life Syariah Dana - Peserta | 1734908000 | 5.22 | | | | PT Capital Life Syariah | 108500000 | 0.3 | | | | PT Astro Global Investment d/h PT Padma Sampurna Aluwung | 1 | 0.001 | | | | Public | 10001000001 | 24.56 | | | | | | | | | As of Sep 30, 2023 | | | | |
|
| History stocks |
Type of ListingDatePrice## of SharesTotal Listed Shares IPO @ Rp 10313-Mar-20201001000000000033250000000
|
| Other infos |
|
| Created date |
| 2023-11-28 15:21:27 |
| Revised date |
| 2023-11-28 15:21:27 |
| Finance |
| PT Metro Healthcare Indonesia Tbk |
| Financial Statetment Date |
| Fiscal Year Ends |
| Months Covered in Income St |
| |
| Summary Covered in Income St |
| Cash and Cash Equivalents |
| Receivables |
| Inventories |
| Current Assets |
| Fixed Assets |
| Other Assets |
| Non Current Assets |
| Total Assets |
| Current Liabilities |
| Longterm Liabilities |
| Total Liabilities |
| Authorized |
| Paid-up Capital |
| Par Value |
| Paid-up Capital Shares |
| Retained Earnings |
| Total Equity |
| Minority Interest |
| |
| Summary of Income Statement |
| Total Sales |
| Cost of Good Sold |
| Gross Profit |
| Operating Profit |
| Other Income |
| Earning Before Tax |
| Tax |
| Net Income |
| Close Price |
| |
| Per Share Data (Rp) |
| Eps (annualized) |
| Book Value |
| |
| Financial Ratios |
| Debt Equity Ratio (X) |
| Roa(%) |
| Roe(%) |
| Npm(%) |
| Opm(%) |
| Gross Profit Margin (%) |
| Total Assets Turnover |
| |
| Cash Flow |
| CF from Operation Activities |
| CF from Investing Activities |
| CF from Financing Activities |
| Net Increase in Cash & Cash Equivalent |
| Cash & Cash Equivalent at Beginning of the Year |
| Cash & Cash Equivalent at The End of the Year |
|
|